TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Ame Bioscience AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
19,272
|
5,802
|
20,052 |
| Financial expenses |
23
|
23
|
96 |
| Earnings before taxes |
3,892
|
1,086
|
4,119 |
| Total assets |
10,149
|
5,294
|
8,101 |
| Current assets |
10,149
|
5,289
|
8,094 |
| Current liabilities |
3,708
|
1,239
|
1,093 |
| Equity capital |
6,441
|
4,055
|
7,008 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
63.5%
|
76.6%
|
86.5% |
| Turnover per employee |
19,272
|
5,802 | |
| Profit as a percentage of turnover |
20.2%
|
18.7%
|
20.5% |
| Return on assets (ROA) |
38.6%
|
20.9%
|
52.0% |
| Current ratio |
273.7%
|
426.9%
|
740.5% |
| Return on equity (ROE) |
60.4%
|
26.8%
|
58.8% |
| Change turnover |
13,470
|
-14,250
|
-4,416 |
| Change turnover % |
232%
|
-71%
|
-18% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.